Overview

Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories

Status:
Completed
Trial end date:
2016-05-24
Target enrollment:
Participant gender:
Summary
This study will be an open label, single dose, randomized, 2 way (2 period) crossover study in healthy adult subjects at a single study center.
Phase:
Phase 1
Details
Lead Sponsor:
Cristcot LLC
Collaborator:
Parexel
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate